What is the global market size of Elastomeric Infusion Pumps Market?

Elastomeric Infusion Pumps Market size was valued at USD 977.84 million in 2021 and is poised to grow from USD 1067.8 million in 2022 to USD 2159.09 million by 2030, at a CAGR of 9.2 % during the forecast period (2023-2030).

Who are the key vendors in the Global Elastomeric Infusion Pumps Market?

The elastomeric infusion systems market exhibits a moderate level of fragmentation and competitiveness. Market players are actively engaged in strategies such as new product launches, collaborations, and innovations to strengthen their market presence and increase their share. These industry participants continually strive to introduce advanced solutions, forge strategic partnerships, and drive innovation, positioning themselves to capture a larger market share in the dynamic elastomeric infusion systems market. 'Baxter International Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Avanos Medical, Inc. (US)', 'Nipro Corporation (Japan)', 'Leventon S.A.U (Spain)', 'Fresenius Kabi AG (Germany)', 'Terumo Corporation (Japan)', 'Smiths Medical (UK)', 'CME Medical (United Kingdom)', 'Vygon Group (France)', 'Q Core Medical Ltd. (Israel)', 'Woo Young Medical Co., Ltd. (South Korea)', 'Romsons Group of Industries (India)', 'Halyard Health, Inc. (US)', 'Sooil Development Co., Ltd. (South Korea)', 'Micrel Medical Devices SA (Switzerland)', 'Coopdech (China)', 'Polymedicure Ltd. (India)', 'Shanghai Kindly Medical Instruments Co., Ltd. (China)', 'Coloplast Group (Denmark)'

What is the key driver of Global Elastomeric Infusion Pumps Market?

The rising incidence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver for the elastomeric infusion pumps market. These pumps provide a reliable and convenient method of delivering medications for long-term management of chronic conditions.

What is the key market trend for Global Elastomeric Infusion Pumps Market?

There was a growing trend towards home healthcare and ambulatory care, driven by factors such as the rising elderly population, preference for cost-effective treatment options, and advancements in medical technology. Elastomeric infusion pumps were being increasingly utilized in homecare settings due to their ease of use, portability, and ability to provide continuous infusion of medications without the need for electronic programming. This trend allowed patients to receive treatment outside of traditional healthcare facilities, promoting patient comfort and reducing the burden on healthcare facilities.

Which region accounted for the largest share in Global Elastomeric Infusion Pumps Market?

In the global elastomeric infusion pumps market, regional insights reveal a dynamic landscape driven by various factors across different regions. North America emerges as the largest market segment, primarily due to the region's advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological advancements. The increasing prevalence of chronic diseases, rising demand for pain management solutions, and extensive adoption of elastomeric infusion pumps contribute to the dominance of North America in the market.

Elastomeric Infusion Pumps Companies

Elastomeric Infusion Pumps Market Competitive Landscape

Elastomeric Infusion Pumps Market Top Player’s Company Profiles

Baxter (US)
Fresenius Kabi AG (Germany)
B. Braun SE (Germany)
Ambu A/S (Denmark)
NIPRO (Japan)
Terumo Corporation (Japan)
AVNS (US)
Vygon Group (France)
Smiths Group plc (UK)
ICU Medical, Inc. (US)
Pajunk GmbH (Germany)
Woo Young Medical Co., Ltd. (South Korea)
Sapphire Medical (Israel)
Ace Medical Co., Ltd. (South Korea)
Eitan Medical (Israel)
Zyno Medical (US)
Epic Medical (Singapore)
Nipro Corporation (Japan)
Daiken Medical Co., Ltd. (Japan)
Coopdech (Japan)
Westmed, Inc. (US)
Flowonix Medical Inc. (US)

Elastomeric Infusion Pumps Market

FAQs

Global Elastomeric Infusion Pumps Market size was valued at USD 638 million in 2022 and is poised to grow from USD 684.57 million in 2023 to USD 1202.87 million by 2031, growing at a CAGR of 7.30% during the forecast period (2024-2031).

Key competitors in the highly competitive elastomeric infusion pump market are Terumo Corporation, Smiths Medical, and Baxter International. These businesses focus on product diversification, technology upgrades, and expanding distribution networks to have an edge in the race. Companies are also investing in alliances and teamwork to raise their market share in developing countries and to cater to the ever-increasing demand for home healthcare solutions. 'Baxter (US) ', 'Fresenius Kabi AG (Germany) ', 'B. Braun SE (Germany) ', 'Ambu A/S (Denmark) ', 'NIPRO (Japan) ', 'Terumo Corporation (Japan) ', 'AVNS (US) ', 'Vygon Group (France) ', 'Smiths Group plc (UK) ', 'ICU Medical, Inc. (US) ', 'Pajunk GmbH (Germany) ', 'Woo Young Medical Co., Ltd. (South Korea) ', 'Sapphire Medical (Israel) ', 'Ace Medical Co., Ltd. (South Korea) ', 'Eitan Medical (Israel) ', 'Zyno Medical (US) ', 'Epic Medical (Singapore) ', 'Nipro Corporation (Japan) ', 'Daiken Medical Co., Ltd. (Japan) ', 'Coopdech (Japan) ', 'Westmed, Inc. (US) ', 'Flowonix Medical Inc. (US)'

Hybridizing Digital Health Solutions: There is a growing usage of elastomeric infusion pumps hyphenated with digital health solutions, encompassing such hybrid solutions as telemedicine platforms and smartphone apps. These hybrid solutions enhance the accuracy and efficiency of therapy through real-time monitoring and adjustment of infusions rates. Furthermore, remote monitoring increases patient safety by allowing medical professionals to monitor the infusion process and take rapid action if needed. Due to this trend, elastomeric pumps are becoming increasingly popular and increasingly applied in home care settings.

Factors driving the expansion of the elastomeric infusion pumps market in North America include an increased need for infusion pumps, especially elastomeric infusion pumps, which would arise from increased incidence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases. There is further a growing demand for more portable and easier-to-use infusion systems as home healthcare services are increasing. Technological advancements in elastomeric pumps for the improvement in the comfort and accuracy of drug administration are expanding the market. Reimbursement policies in favor and a strong healthcare infrastructure are bolstering the growth for this market. In addition, with the aging population in North America, there is an increased demand for infusion pumps for managing chronic diseases.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Elastomeric Infusion Pumps Market Competitive Landscape

Elastomeric Infusion Pumps Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Elastomeric Infusion Pumps Market Competitive Landscape

Elastomeric Infusion Pumps Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Elastomeric Infusion Pumps Market?

Who are the key vendors in the Elastomeric Infusion Pumps Market?

What is the key driver of Elastomeric Infusion Pumps Market?

What is the key market trend for Elastomeric Infusion Pumps Market?

Which region accounted for the largest share in Elastomeric Infusion Pumps Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300